Brent McKenzie is the head of Translational Immunology at Genentech South San Francisco. He has over 15 years’ experience in early stage drug discovery and development. An Immunologist with extensive background in in-vivo pharmacology, Autoimmunity, Inflammation, Fibrosis, Ocular disease, Infection, Coagulation, Cancer, Metabolism & Vaccines. A leader of large multidisciplinary teams, BD deals and company acquisitions. His team at Genentech works on large and small molecule drug discovery and development for inflammatory, ocular, fibrotic and infectious diseases.